Back to Journals » Therapeutics and Clinical Risk Management » Volume 19

Original Research

Lenvatinib Plus PD-1 Inhibitors versus Regorafenib in Patients with Advanced Hepatocellular Carcinoma After the Failure of Sorafenib: A Retrospective Study

       
Total article views   HTML views PDF downloads Totals
1,147 Dovepress* 1,072+ 42 1,114
PubMed Central* 75 50 125
Totals 1,147 92 1,239
*Since 24 October 2023

View citations on PubMed Central and Google Scholar